Tumors use active immunosuppressive mechanisms to evade immune recognition and shape the local inflammatory environment. In this issue of Immunity, Bonavita et al. report that tumor-derived PGE2 blocks early activation of natural killer cells and interferes with subsequent adaptive immune cell recruitment to the tumor. Copyright © 2020 Elsevier Inc. All rights reserved.
Nelson H Knudsen, Robert T Manguso. Tumor-Derived PGE2 Gives NK Cells a Headache. Immunity. 2020 Dec 15;53(6):1131-1132
PMID: 33326763
View Full Text